Psychedelic therapy in depression and substance use disorders
European Journal of Neuroscience May 21, 2024 Nur Damla Korkmaz, Ugur Cikrikcili, Merve Akan et al. 19 citations
Abstract Psychoactive substances obtained from botanicals have been applied for a wide variety of purposes in the rituals of different cultures for thousands of years. Classical psychedelics from N,N′‐dimethyltryptamine, psilocybin, mescaline and various lysergamides cause specific alterations in perception, emotion and cognition by acting through serotonin 5‐HT 2A receptor activation. Lysergic...